Disease-Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy.

Ueda, Mitsuharu; Misumi, Yohei; Nomura, Toshiya; Tasaki, Masayoshi; Yamakawa, Shiori; Obayashi, Konen; Yamashita, Taro; Ando, Yukio

Ueda, Mitsuharu; Misumi, Yohei; Nomura, Toshiya; Tasaki, Masayoshi; Yamakawa, Shiori; Obayashi, Konen; Yamashita, Taro; Ando, Yukio.

Afiliación

Ueda M; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Misumi Y; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.
Nomura T; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Tasaki M; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.
Yamakawa S; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Obayashi K; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.
Yamashita T; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Ando Y; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.

Ann Neurol ; 95(2): 230-236, 2024 Feb.

Article en En | MEDLINE | ID: mdl-38053464

Asunto(s)

Neuropatías Amiloides Familiares; Neuropatías Amiloides; Polineuropatías; Humanos; Neuropatías Amiloides Familiares/tratamiento farmacológico; Neuropatías Amiloides Familiares/genética; Prealbúmina/genética; Estudios Retrospectivos; Neuropatías Amiloides/tratamiento farmacológico; Neuropatías Amiloides/genética; Amiloide

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polineuropatías / Neuropatías Amiloides / Neuropatías Amiloides Familiares Límite: Humans Idioma: En Revista: Ann Neurol Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google